bioengineer.org /3 days ago

Colorectal Carcinoma Biopsies Show Ubiquitous PD-L1 and Bcl-2 Protein Expression

A hospital-based evaluation of sixty male colorectal carcinoma patients in Anbar Governorate detected widespread immunohistochemical expression of both PD-L1 and Bcl-2 proteins acr...

Read source
fightaging.org /1 month ago

PD-L1 Blockade in the Brain Restores Measures of Glial Cell Function

PD-L1 found on the surface of cells is a well known immune checkpoint protein. When it binds to the receptor PD-1 found on the surface of T cells and B cells, it acts to suppress i...

Read source
fightaging.org /1 week ago

The DNA Damage Response Induces PD-L1 Expression and Immune Evasion in Senescent Cells

Senescent cells are constantly created throughout life, but accumulate in aged tissues as a result of a growing age-related failure of the immune system to promptly clear these cel...

Read source
bioengineer.org /1 month ago

Immune Cells Cluster Around Blood Vessels to Predict Lung Cancer Immunotherapy Success

Immunotherapy has transformed the treatment landscape for non-small cell lung cancer, the most common form of lung malignancy worldwide, yet a stubborn problem persists: only a sub...

Read source
bioengineer.org /1 month ago

Hidden armies inside glioblastoma: exhausted T cells hint at new immunotherapy routes

Single-cell analysis of 56 glioblastoma tumors reveals that T-cell-rich cases harbor clonally expanded, LAG3-high CD8 T cells that may be tumor-reactive, opening new avenues for im...

Read source
bioengineer.org /1 week ago

Immunotherapy Combined With Chemotherapy Extends Survival in Advanced SMARCA4-Deficient Lung Cancer

A real-world retrospective study demonstrates that adding first-line immunotherapy to chemotherapy significantly prolongs median overall survival by 23 months in advanced SMARCA4-d...

Read source
bioengineer.org /2 hours ago

Anti-PD-1 Therapy Modulates HIV-Specific CD8+ T Cells in Men with HIV

A clinical trial of anti-PD-1 therapy in men with HIV and cancer demonstrates complex changes in HIV-specific CD8+ T-cell phenotypes and clonal distribution.

Read source
labiotech.eu /1 month ago

B7-H3 ADCs: A new contender in small cell lung cancer and beyond 

Delve into the field of B7-H3 ADCs, a new contender in SCLC cancer as Hansoh Pharma and Medilink bring momentum with positive results. The post B7-H3 ADCs: A new contender in small...

Read source
bioengineer.org /4 days ago

Local IL-12 and Flt3L mRNA Nanoparticles Control Checkpoint-Resistant Melanoma in Mice

Intratumoral co-administration of IL-12 and Flt3L mRNA lipid nanoparticles controlled anti-PD-1-refractory melanoma in mouse models by coordinating dendritic, natural killer, and T...

Read source
rna-seqblog.com /3 weeks ago

Overlooked ‘off switch’ in lung tumors may explain why immunotherapy doesn’t work for everyone

Long-read RNA sequencing reveals STAT2 splicing patterns associated with immunotherapy response in lung cancer...

Read source
qchron.com /4 weeks ago

New data on Lilly's investigational treatment olomorasib at ESMO 2026 show durable first-line activity in KRAS G12C-muta...

Data presented at ESMO highlight the promising efficacy of olomorasib in combination with standard-of-care immunotherapy with or without chemotherapy in first-line advanced KRAS G1...

Read source
genengnews.com /3 days ago

Targeting Folate Receptor Reverses Colorectal Cancer’s Resistance to Immunotherapy in Mice

Targeting FOLR1 with an approved antibody-drug conjugate restored anti-tumor immunity and enhanced anti-PD-1 effectiveness in colorectal cancer, overcoming immune evasion in mouse...

Read source
journals.plos.org /1 month ago

Multi-omics analysis of high-grade serous ovarian cancers reveals heterogeneity and distinct immunological patterns base...

by Jing Qian, Rania Bassiouni, Yuxin Jin, Seeta Rajpara, Monica Neuman, Varun U. Khetan, Bodour Salhia, David W. Craig, Joseph W. Carlson, Lynda D. Roman, John D. Carpten High-gra...

Read source
newswire.com /1 week ago

Aptevo Presents Preclinical Data at SITC 2026 Showing Potential to Overcome Immune Suppression in Solid Tumors

In lab studies, APVO451 and APVO452 helped immune cells kill cancer cells despite conditions that suppress immune activity - offering potential for difficult-to-treat solid tumorsP...

Read source
bioengineer.org /3 weeks ago

ORC1 Protein Rises with HBV Liver Disease Progression and Flags Poorer Survival

A study of 178 patients found that ORC1 expression rises from chronic hepatitis B to cirrhosis to HBV-associated liver cancer and that high expression is associated with poorer sur...

Read source
journals.plos.org /1 month ago

Natural killer cell receptor signaling and activation depend on cell cycle stages

by Darren Wethington, Indrani Nayak, Helle Jensen, William C. Stewart, Oscar A. Aguilar, Shih-Yu Chen, Garry P. Nolan, Gregory K. Behbehani, Lewis L. Lanier, Jayajit Das Natural K...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.